{{expand|time=2017-12-24T17:31:14+00:00}}
{{medical}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 414053518
| IUPAC_name = (6''R'',7''R'')-7-{[(2''Z'')-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino-acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
| image = Carnidazole Structual Formula V2.svg
| width = 200

<!--Clinical data-->
| tradename = Generic (formerly ''Vantin'')
| Drugs.com = {{drugs.com|monograph|vantin}}
| MedlinePlus = a698024
| pregnancy_AU = B1
| pregnancy_US = B
| legal_AU = <!-- Unscheduled / S2 / S3 / S4  / S8 -->
| legal_CA = <!--                             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = Rx-only
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability = 50%
| protein_bound = 21% to 29%
| metabolism = Negligible. Cefpodoxime proxetil is metabolized to cefpodoxime by the [[liver|liver]]
| elimination_half-life = 2 hours
| excretion = [[Kidney|Renal]], unchanged

<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 82619-04-3
| ATC_prefix = J01
| ATC_suffix = DD13
| PubChem = 6335986
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB01416
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4891496
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 7R4F94TVGY
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07650
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 3504
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1672

<!--Chemical data-->
| C=15 | H=17 | N=5 | O=6 | S=2 
| molecular_weight = 427.458 g/mol
| smiles = O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)C(=N\OC)/c3nc(sc3)N)COC)C(=O)O
| InChI = 1/C15H17N5O6S2/c1-25-3-6-4-27-13-9(12(22)20(13)10(6)14(23)24)18-11(21)8(19-26-2)7-5-28-15(16)17-7/h5,9,13H,3-4H2,1-2H3,(H2,16,17)(H,18,21)(H,23,24)/b19-8-/t9-,13-/m1/s1
| InChIKey = WYUSVOMTXWRGEK-HBWVYFAYBO
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C15H17N5O6S2/c1-25-3-6-4-27-13-9(12(22)20(13)10(6)14(23)24)18-11(21)8(19-26-2)7-5-28-15(16)17-7/h5,9,13H,3-4H2,1-2H3,(H2,16,17)(H,18,21)(H,23,24)/b19-8-/t9-,13-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = WYUSVOMTXWRGEK-HBWVYFAYSA-N
}}
'''头孢泊肟酯'''（{{lang-en|Cefpodoxime Proxetil}}），是一种第三代[[头孢菌素|头孢菌素]]。
它对绝大多数的[[革兰氏阳性|革兰氏阳性]]和[[革兰氏阳阴性|革兰氏阳阴性]]的生物都有作用，除了[[绿脓杆菌|绿脓杆菌]]、[[肠球菌|肠球菌]]和{{link-en|脆弱拟杆菌|Bacteroides fragilis}}等例外。现在它在美国仍然在常规准备阶段，通常用于治疗急性[[中耳炎|中耳炎]]、[[咽炎|咽炎]]、[[鼻窦炎|鼻窦炎]]和淋病。

==分子式==
[[Image:Cefpodoxime_proxetil.svg|thumb]]

==外部链接==
* {{PubChem|6526396}} - cefpodoxime proxetil
* [https://web.archive.org/web/20060325011459/https://www.pfizer.com/pfizer/download/uspi_vantin.pdf  Vantin Tablets and Oral Suspension Torpod (Torrent)Full U.S. Prescribing Information] (from manufacturer's website)
* [http://www.simplicef.com/images/simplicef_pre_info.pdf Simplicef]{{Wayback|url=http://www.simplicef.com/images/simplicef_pre_info.pdf |date=20070929031241 }} (from manufacturer's website)
* https://web.archive.org/web/20190425082636/https://www.intaspharma.com/index.php?option=com_djcatalog2&view=itemstable&cid=3&Itemid=77
{{细胞壁破坏性抗生素}}

[[Category:头孢菌素|Category:头孢菌素]]